ISE:GL9

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Glanbia plc operates as a nutrition company. More Details


Snowflake Analysis

Excellent balance sheet established dividend payer.


Similar Companies

Share Price & News

How has Glanbia's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GL9's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-0.6%

GL9

-1.5%

IE Food

-1.0%

IE Market


1 Year Return

-21.6%

GL9

-3.6%

IE Food

4.1%

IE Market

Return vs Industry: GL9 underperformed the Irish Food industry which returned -2.4% over the past year.

Return vs Market: GL9 underperformed the Irish Market which returned 3.6% over the past year.


Shareholder returns

GL9IndustryMarket
7 Day-0.6%-1.5%-1.0%
30 Day-6.8%-3.2%4.7%
90 Day-20.7%-3.3%5.2%
1 Year-19.4%-21.6%-1.3%-3.6%5.4%4.1%
3 Year-45.6%-49.0%16.2%2.6%12.3%7.1%
5 Year-48.8%-52.7%33.8%20.4%22.1%13.5%

Price Volatility Vs. Market

How volatile is Glanbia's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Glanbia undervalued compared to its fair value and its price relative to the market?

39.6%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GL9 (€8.34) is trading below our estimate of fair value (€13.82)

Significantly Below Fair Value: GL9 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GL9's PE Ratio (16.2x) is in line with the XE Food industry average.

PE vs Market: GL9 is good value based on its PE Ratio (16.2x) compared to the Irish market (21.3x).


Price to Earnings Growth Ratio

PEG Ratio: GL9 is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: GL9 is overvalued based on its PB Ratio (1.5x) compared to the XE Food industry average (1.1x).


Next Steps

Future Growth

How is Glanbia forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

21.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GL9's forecast earnings growth (21.5% per year) is above the savings rate (0.7%).

Earnings vs Market: GL9's earnings (21.5% per year) are forecast to grow slower than the Irish market (38.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GL9's revenue (4.9% per year) is forecast to grow slower than the Irish market (9.6% per year).

High Growth Revenue: GL9's revenue (4.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GL9's Return on Equity is forecast to be low in 3 years time (12.5%).


Next Steps

Past Performance

How has Glanbia performed over the past 5 years?

1.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GL9 has a large one-off loss of €50.0M impacting its July 4 2020 financial results.

Growing Profit Margin: GL9's current net profit margins (3.8%) are lower than last year (6.3%).


Past Earnings Growth Analysis

Earnings Trend: GL9's earnings have grown by 1.8% per year over the past 5 years.

Accelerating Growth: GL9's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: GL9 had negative earnings growth (-30.2%) over the past year, making it difficult to compare to the Food industry average (5.6%).


Return on Equity

High ROE: GL9's Return on Equity (9%) is considered low.


Next Steps

Financial Health

How is Glanbia's financial position?


Financial Position Analysis

Short Term Liabilities: GL9's short term assets (€1.0B) exceed its short term liabilities (€758.3M).

Long Term Liabilities: GL9's short term assets (€1.0B) exceed its long term liabilities (€903.1M).


Debt to Equity History and Analysis

Debt Level: GL9's debt to equity ratio (47.6%) is considered high.

Reducing Debt: GL9's debt to equity ratio has reduced from 68.5% to 47.6% over the past 5 years.

Debt Coverage: GL9's debt is well covered by operating cash flow (33.8%).

Interest Coverage: GL9's interest payments on its debt are well covered by EBIT (8.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Glanbia current dividend yield, its reliability and sustainability?

3.19%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GL9's dividend (3.19%) is higher than the bottom 25% of dividend payers in the Irish market (2.35%).

High Dividend: GL9's dividend (3.19%) is low compared to the top 25% of dividend payers in the Irish market (4.38%).


Stability and Growth of Payments

Stable Dividend: GL9's dividends per share have been stable in the past 10 years.

Growing Dividend: GL9's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (51.6%), GL9's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GL9's dividends in 3 years are forecast to be well covered by earnings (33.7% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.4yrs

Average management tenure


CEO

Siobhán Talbot (56 yo)

6.92yrs

Tenure

€1,394,000

Compensation

Ms. Siobhán Talbot, B.Comm., FCA has been the Group Managing Director of Glanbia plc since November 12, 2013 and its Executive Director since July 1, 2009. Ms. Talbot served as Group Finance Director at Gl ...


CEO Compensation Analysis

Compensation vs Market: Siobhán's total compensation ($USD1.65M) is about average for companies of similar size in the Irish market ($USD1.76M).

Compensation vs Earnings: Siobhán's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Siobhán Talbot
Group MD & Executive Director6.92yrs€1.39m0.11%
€ 2.7m
Mark Garvey
Group Finance Director & Executive Director6.92yrs€1.02m0.038%
€ 928.0k
Brian Phelan
Chief Executive Officer of Glanbia Nutritionals1.75yrs€289.00k0.053%
€ 1.3m
Hugh McGuire
Chief Executive Officer of Glanbia Performance Nutrition1.75yrs€222.00k0.037%
€ 914.2k
Liam Hennigan
Group Director of Strategic Planning & Investor Relationsno datano datano data
Martha Kavanagh
Head of Corporate Communicationsno datano datano data
Tom Tench
Group Corporate Development Director5.58yrsno datano data
Michael Patten
Director of Group Human Resources & Corporate Affairs5.83yrsno datano data
Michael Horan
Company Secretary15.33yrsno data0.014%
€ 350.1k
Jim Bergin
Chief Executive of Glanbia Ingredients Ireland Limited3.25yrsno datano data
Colin Gordon
Chief Executive Officer of Consumer Products14.75yrsno datano data
Colm Eustace
Chief Executive Officer of Agribusiness14.75yrsno datano data

6.4yrs

Average Tenure

56yo

Average Age

Experienced Management: GL9's management team is seasoned and experienced (6.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Siobhán Talbot
Group MD & Executive Director6.92yrs€1.39m0.11%
€ 2.7m
Mark Garvey
Group Finance Director & Executive Director6.92yrs€1.02m0.038%
€ 928.0k
Daniel O'Connor
Senior Independent Director1.42yrs€95.00k0.0026%
€ 64.0k
Michael Walsh
Member of the US Advisory Boardno datano datano data
Patrick Coveney
Independent Non-Executive Director6.42yrs€85.00k0.0013%
€ 32.5k
Donard Gaynor
Independent Non-Executive Chairmanno data€95.00k0.0034%
€ 83.5k
Martin Keane
Director14.42yrs€113.00k0.011%
€ 281.4k
Wayne Seltzer
Member of The US Advisory Boardno datano datano data
John Murphy
Non-Executive Director10.33yrs€60.00k0.0025%
€ 60.8k
Brendan Hayes
Non-Executive Director3.33yrs€43.00k0.012%
€ 290.5k
Patrick Murphy
Vice Chairman2.33yrs€60.00k0.0039%
€ 96.0k
Vincent Gorman
Non-Executive Director7.33yrs€43.00k0.0020%
€ 50.2k

6.9yrs

Average Tenure

61yo

Average Age

Experienced Board: GL9's board of directors are considered experienced (6.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: GL9 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Glanbia plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Glanbia plc
  • Ticker: GL9
  • Exchange: ISE
  • Founded: 1964
  • Industry: Packaged Foods and Meats
  • Sector: Food, Beverage & Tobacco
  • Market Cap: €2.462b
  • Shares outstanding: 295.23m
  • Website: https://www.glanbia.com

Number of Employees


Location

  • Glanbia plc
  • Glanbia House
  • Ring Road
  • Kilkenny
  • Co. Kilkenny
  • R95 E866
  • Ireland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GLBLSE (London Stock Exchange)YesOrdinary SharesGBEURJan 1992
GL9ISE (Irish Stock Exchange)YesOrdinary SharesIEEURJan 1992
GLAP.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJan 1992
GL9IBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURJan 1992
GL9DB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 1992
GLBLBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURJan 1992
GLB NBMV (Bolsa Mexicana de Valores)YesOrdinary SharesMXMXNJan 1992
GLAP.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDOct 1998

Biography

Glanbia plc operates as a nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufact ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/23 21:46
End of Day Share Price2020/10/23 00:00
Earnings2020/07/04
Annual Earnings2020/01/04


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.